Acadia Healthcare (NASDAQ:ACHC - Get Free Report)'s stock had its "sell (d)" rating restated by Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
Several other research analysts have also weighed in on the stock. Barclays lowered their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Mizuho lowered their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 13th. KeyCorp reduced their price target on shares of Acadia Healthcare from $55.00 to $35.00 and set an "overweight" rating on the stock in a report on Wednesday. Raymond James Financial upped their price target on shares of Acadia Healthcare from $26.00 to $30.00 and gave the company an "outperform" rating in a report on Friday, October 3rd. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $25.00 price target on shares of Acadia Healthcare in a report on Tuesday. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.09.
View Our Latest Analysis on ACHC
Acadia Healthcare Stock Performance
Shares of NASDAQ:ACHC traded down $1.20 on Wednesday, reaching $26.04. The company's stock had a trading volume of 1,081,330 shares, compared to its average volume of 2,379,767. The stock's 50-day moving average is $22.43 and its two-hundred day moving average is $23.46. Acadia Healthcare has a 52-week low of $17.13 and a 52-week high of $60.52. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market capitalization of $2.40 billion, a P/E ratio of 17.23, a PEG ratio of 5.24 and a beta of 0.90.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. During the same period in the prior year, the company earned $0.91 earnings per share. The business's revenue was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, sell-side analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of ACHC. Allworth Financial LP boosted its holdings in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company's stock valued at $31,000 after buying an additional 1,177 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock valued at $32,000 after buying an additional 497 shares during the period. UMB Bank n.a. boosted its holdings in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares during the period. Finally, CWM LLC lifted its position in Acadia Healthcare by 105.1% in the 2nd quarter. CWM LLC now owns 2,633 shares of the company's stock valued at $60,000 after purchasing an additional 1,349 shares during the last quarter.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.